For patients with atrial fibrillation who need protection from stroke and other complications after ablation, left atrial ...

This repository contains NVIDIA's official implementation of the Kubernetes device plugin. As of v0.15.0 this repository also holds the implementation for GPU Feature Discovery labels, for further ...

Late-breaking data reinforce long-term benefits of Abbott's Amplatzer Amulet device for people with atrial fibrillation at risk of stroke: Abbott Park, Illinois Wednesday, Novembe ...

The American Heart Association and the Arizona Cardinals gathered representatives from 12 local schools for cardiopulmonary ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Abbott (NYSE:ABT) announced new data supporting its Amplatzer Amulet left atrial appendage (LAA) occluder system.

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global ...

Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on BSX stock, giving a Buy rating yesterday.Don't Miss our Black ...

Marlborough, Massachusetts Tuesday, November 19, 2024, 17:00 Hrs [IST] ...

At the moment, the company is developing novel therapeutic approaches for patients with underserved heart issues, such as ...

Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.

The trial compared the stroke prevention device for left atrial appendage closure to blood thinners in people who underwent ...